Loading...
Loading...
Among the 7 tracked institutional investors we monitor, PCRX (PACIRA BIOSCIENCES INC) is held with a combined value of $382.84M across 16,241,202 shares. The largest holder is BlackRock, Inc. with a position worth $152.22M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 2 funds increased their holdings. 4 funds reduced their position.
Total Institutional Value
$382.84M
Total Shares Held
16,241,202
Institutional Holders
7
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $152.22M | 0.00% | -4.7% |
| 2 | VANGUARD GROUP INC | $124.56M | 0.00% | New |
| 3 | STATE STREET CORP | $43.38M | 0.00% | +1.9% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | $41.26M | 0.06% | -3.1% |
| 5 | CITADEL ADVISORS LLC | $18.02M | 0.00% | -5.9% |
| 6 | FMR LLC | $2.11M | 0.00% | +26.5% |
| 7 | MILLENNIUM MANAGEMENT LLC | $1.29M | 0.00% | -53.5% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of PCRX with a position worth $152.22M, representing 0.00% of their portfolio. In total, 7 institutional investors hold PCRX with a combined value of $382.84M.
In the most recent quarter, 1 fund opened a new position in PCRX. Additionally, 2 increased their holdings and 4 reduced their positions.
Institutional investors hold $382.84M worth of PCRX stock across 7 positions. The largest institutional holder is BlackRock, Inc. with $152.22M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For PCRX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their PCRX positions.